Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 2
1954 1
1963 1
1971 1
1972 1
1975 2
1979 1
1981 1
1985 1
1996 1
2000 2
2002 3
2003 1
2005 4
2006 4
2007 2
2008 3
2009 4
2010 2
2011 4
2012 5
2013 5
2014 4
2015 3
2016 8
2017 6
2018 7
2019 14
2020 13
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 23095052

93 results
Results by year
Filters applied: . Clear all
Page 1
Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report.
Crippa JA, Hallak JE, Machado-de-Sousa JP, Queiroz RH, Bergamaschi M, Chagas MH, Zuardi AW. Crippa JA, et al. J Clin Pharm Ther. 2013 Apr;38(2):162-4. doi: 10.1111/jcpt.12018. Epub 2012 Oct 24. J Clin Pharm Ther. 2013. PMID: 23095052
Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.
Allsop DJ, Copeland J, Lintzeris N, Dunlop AJ, Montebello M, Sadler C, Rivas GR, Holland RM, Muhleisen P, Norberg MM, Booth J, McGregor IS. Allsop DJ, et al. JAMA Psychiatry. 2014 Mar;71(3):281-91. doi: 10.1001/jamapsychiatry.2013.3947. JAMA Psychiatry. 2014. PMID: 24430917 Clinical Trial.
Cannabinoid replacement therapy (CRT): Nabiximols (Sativex) as a novel treatment for cannabis withdrawal.
Allsop DJ, Lintzeris N, Copeland J, Dunlop A, McGregor IS. Allsop DJ, et al. Clin Pharmacol Ther. 2015 Jun;97(6):571-4. doi: 10.1002/cpt.109. Epub 2015 Apr 17. Clin Pharmacol Ther. 2015. PMID: 25777582 Review.
Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings.
Trigo JM, Lagzdins D, Rehm J, Selby P, Gamaleddin I, Fischer B, Barnes AJ, Huestis MA, Le Foll B. Trigo JM, et al. Drug Alcohol Depend. 2016 Apr 1;161:298-306. doi: 10.1016/j.drugalcdep.2016.02.020. Epub 2016 Feb 23. Drug Alcohol Depend. 2016. PMID: 26925704 Free PMC article. Clinical Trial.
Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms.
Budney AJ, Vandrey RG, Hughes JR, Moore BA, Bahrenburg B. Budney AJ, et al. Drug Alcohol Depend. 2007 Jan 5;86(1):22-9. doi: 10.1016/j.drugalcdep.2006.04.014. Epub 2006 Jun 12. Drug Alcohol Depend. 2007. PMID: 16769180
Nabilone therapy for cannabis withdrawal presenting as protracted nausea and vomiting.
Lam PW, Frost DW. Lam PW, et al. BMJ Case Rep. 2014 Sep 22;2014:bcr2014205287. doi: 10.1136/bcr-2014-205287. BMJ Case Rep. 2014. PMID: 25246463 Free PMC article.
[Cannabis withdrawal syndrome in patients with cannabis dependence only, and in patients with cannabis and opioid dependence].
Vorspan F, Guillem E, Bloch V, Bellais L, Sicot R, Noble F, Lepine JP, Gorelick DA. Vorspan F, et al. Encephale. 2011 Sep;37(4):266-72. doi: 10.1016/j.encep.2010.12.007. Epub 2011 Feb 5. Encephale. 2011. PMID: 21981886 French.
Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol.
Demirakca T, Sartorius A, Ende G, Meyer N, Welzel H, Skopp G, Mann K, Hermann D. Demirakca T, et al. Drug Alcohol Depend. 2011 Apr 1;114(2-3):242-5. doi: 10.1016/j.drugalcdep.2010.09.020. Epub 2010 Nov 2. Drug Alcohol Depend. 2011. PMID: 21050680
The cannabis withdrawal syndrome.
Budney AJ, Hughes JR. Budney AJ, et al. Curr Opin Psychiatry. 2006 May;19(3):233-8. doi: 10.1097/01.yco.0000218592.00689.e5. Curr Opin Psychiatry. 2006. PMID: 16612207 Review.
Differential effect of cannabinol and cannabidiol on THC-induced responses during abstinence in morphine-dependent rats.
Hine B, Torrelio M, Gershon S. Hine B, et al. Res Commun Chem Pathol Pharmacol. 1975 Sep;12(1):185-8. Res Commun Chem Pathol Pharmacol. 1975. PMID: 1237925
93 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page